Finance

Lists
4506:TYO
Sumitomo Pharma Co Ltd
JP¥ 1,613.50
-1.31%
(-21.50) 1D
10-р сарын 2, 15:30:00 (GMT+9)  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4506...
Open
JP¥ 1,611
High
JP¥ 1,628
Low
JP¥ 1,600
Mkt. cap
724.79Т
Avg. vol.
3.57 сая
Volume
2.70 сая
P/E ratio
5.77
52-wk high
JP¥ 3,288
52-wk low
JP¥ 1,188
EPS
JP¥ 280
Shares outstanding
397.30 сая
No. of employees
3 мян
Open
JP¥ 1,611
High
JP¥ 1,628
Low
JP¥ 1,600
Mkt. cap
724.79Т
Avg. vol.
3.57 сая
Volume
2.70 сая
P/E ratio
5.77
52-wk high
JP¥ 3,288
52-wk low
JP¥ 1,188
EPS
JP¥ 280
Shares outstanding
397.30 сая
No. of employees
3 мян
News stories
From web sources and news partners
Profile
Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka. Wikipedia
About Sumitomo Pharma Co Ltd
CEO-
Employees3.12 мян
Founded1897 оны 5-р сарын 14
HeadquartersОсака, Osaka, Япон
SectorPharmaceutical industry
Last report
2026 оны 7-р сарын 31
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
129.50Т / 114.10Т
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
119.12Т
120.62Т
105.55Т
129.50Т
Cost of goods sold
45.59 тэрбум
55.44 тэрбум
51.26 тэрбум
61.41 тэрбум
Cost of revenue
45.59 тэрбум
55.44 тэрбум
51.26 тэрбум
61.41 тэрбум
Research and development expenses
9.35 тэрбум
10.35 тэрбум
16.12 тэрбум
11.43 тэрбум
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40.90 тэрбум
42.94 тэрбум
43.52 тэрбум
39.24 тэрбум
Operating expense
-1.04 тэрбум
52.19 тэрбум
110.09Т
50.33 тэрбум
Total operating expenses
44.55 тэрбум
107.63Т
161.36Т
111.74Т
Operating income
74.57 тэрбум
13.00 тэрбум
-55.81 тэрбум
17.75 тэрбум
Other non operating income
-
-
-1.64 тэрбум
-
EBT including unusual items
80.87 тэрбум
8.74 тэрбум
-1.20 тэрбум
18.30 тэрбум
EBT excluding unusual items
80.87 тэрбум
8.74 тэрбум
-51.00 тэрбум
18.30 тэрбум
Income tax expense
-6.78 тэрбум
-80.00 сая
-383.00 сая
1.30 тэрбум
Effective tax rate
-8.39%
-0.92%
32.05%
7.09%
Other operating expenses
-51.30 тэрбум
-1.10 тэрбум
50.45 тэрбум
-337.00 сая
Net income
87.65 тэрбум
8.82 тэрбум
-812.00 сая
17.00 тэрбум
Net profit margin
73.58%
7.31%
-0.77%
13.13%
Earnings per share
-
-
-
-
Interest and investment income
5.11 тэрбум
258.00 сая
4.64 тэрбум
2.20 тэрбум
Interest expense
-
-5.14 тэрбум
-
-2.09 тэрбум
Net interest expenses
5.11 тэрбум
-4.88 тэрбум
4.64 тэрбум
107.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
79.85 тэрбум
18.32 тэрбум
-52.48 тэрбум
22.65 тэрбум
Gain or loss from assets sale
1.96 тэрбум
-
-
-
AI content may include mistakes. Learn more
Google аппс